Innoviva News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

14.07.24	15 Healthcare Stocks Hit New Highs: Did You Spot These Winners? (RTTNews)
18.06.24	Analyst Projects Strong Growth for GSK-Innoviva Partnered Respiratory Drugs (Benzinga)
19.04.23	Can The Proposed Antibiotic For Multidrug-Resistant Infections Fuel Innoviva's Revenue Growth? (RTTNews)
18.04.23	MÄRKTE USA/Wall Street dürfte Schwung des späten Vortageshandels halten (Dow Jones)
14.07.22	Royalty Pharma To Buy Royalty Interest In Trelegy Ellipta From Theravance And Innoviva (RTTNews)
11.07.22	Innoviva To Acquire La Jolla Pharma In $149 Mln Deal (RTTNews)
08.07.22	Innoviva Announces Expiration of Cash Tender Offer for Shares of Entasis Therapeutics Holdings Inc. (Businesswire)
23.05.22	Innoviva Agrees To Acquire Entasis Therapeutics For $2.20/Shr Cash (RTTNews)
23.05.22	Innoviva to Acquire Entasis Therapeutics (Businesswire)
20.05.21	Innoviva To Repurchase GSK's 32% Stake In Company For $392 Mln (RTTNews)
10.09.20	AMPE Says Ampion Improves COVID-19 Symptoms, AMYT At Ease, ITCI Impresses With Depression Trial Data (RTTNews)
15.02.19	Innoviva, Inc. -- Moody's announces completion of a periodic review of ratings of Innoviva, Inc. (Moodys)
14.01.19	Innoviva's On A Roll… (RTTNews)
21.09.18	Trelegy Ellipta Gets Positive CHMP Opinion Supporting Expanded COPD Indication (RTTNews)
19.04.18	GlaxoSmithKline: IMPACT Study Shows Benefits Of Trelegy Ellipta In COPD Patients (RTTNews)
18.04.18	GlaxoSmithKline, Innoviva Says IMPACT Study Shows Benefits Of Trelegy Ellipta (RTTNews)
17.04.18	Kyle Schmidt, CFP® Joins BIP Wealth (PR Newswire)
08.03.18	Innoviva, GSK: EU Approves Label Update To Relvar Ellipta In Asthma Patients (RTTNews)
14.02.18	GSK Submits IMPACT Data To EU To Support Trelegy Ellipta's Expanded Labelling (RTTNews)
13.02.18	Sarissa Capital Reconstitutes Innoviva Board Of Directors (PR Newswire)
20.12.17	Kao acquiert Oribe Hair Care de Luxury Brand Partners (PR Newswire)
11.12.17	Nestlé Health Science Launches Educational Website to Prepare Patients for Major Surgery with IMPACT Advanced Recovery® Drink (PR Newswire)
20.11.17	TESARO, Inc. Co-Founders named Entrepreneur Of The Year® 2017 National Overall Award winners (PR Newswire)
17.11.17	FDA Nod For Label Expansion Of Sutent, Egalet Flies, Double Blessing For Roche (RTTNews)
09.10.17	New Drugs Approved In September (RTTNews)
19.09.17	Trelegy Ellipta approved as the first once-daily single inhaler triple therapy for the treatment of appropriate patients with COPD in the US (PR Newswire)
18.09.17	FDA Nod For NEOS, One Step Closer To EU Approval Are GSK, TSRO, On Watch Is MTFB (RTTNews)
15.09.17	GSK, Innoviva: Trelegy Ellipta Gets CHMP Positive Opinion In Europe For COPD (RTTNews)
06.08.17	Florida Truck Drivers Gearing up for Industry's Top Prize (PR Newswire)
01.08.17	Innoviva, Inc. -- Moody's assigns B3 CFR to Innoviva; stable outlook (Moodys)
21.07.17	GSK Submits EU Filing For Extended Use Of Relvar Ellipta (RTTNews)
17.07.17	Initiating Research Reports on Application Software Equities -- Sphere 3D, Cadence Design Systems, Innoviva, and Shopify (PR Newswire)
09.06.17	Technical Snapshots for These Application Software Stocks -- Cadence Design Systems, Shopify, Sphere 3D, and Innoviva (PR Newswire)
05.05.17	GSK And Innoviva Announce Positive Results From SLS In Asthma (RTTNews)
28.04.17	How These Application Software Stocks are Faring? -- Zendesk, LogMeIn, Innoviva, and Rubicon Project (PR Newswire)
26.04.17	Sarissa Asks Innoviva Directors To Explain Continued Director Over-Compensation Despite Promises To Cut Costs (PR Newswire)
17.04.17	Sarissa Capital States: Innoviva Already Appears To Renege On Cost Cuts; Innoviva Thinks Its Bad Corporate Governance Is Not A Problem (PR Newswire)
17.04.17	Sarissa Urges Shareholders To See Through Innoviva's Last Minute Flip-Flop On Cost Cuts; Notes Conspicuous Absence Of Promises To Fix Bad Corporate Governance (PR Newswire)
13.04.17	Sarissa Capital Urges Shareholders Of Innoviva, Inc.: Follow The Recommendations Of ISS, Glass Lewis And Egan-Jones; Vote On The Gold Card For Sarissa Nominees (PR Newswire)
12.04.17	Sarissa Capital Files Presentation In Proxy Contest With Innoviva (PR Newswire)
12.04.17	Egan-Jones Supports All Three Sarissa Capital Nominees For Innoviva Board (PR Newswire)
11.04.17	Sarissa Capital Is Concerned That Innoviva Will Waste Shareholder Money On Imprudent Acquisitions (PR Newswire)
10.04.17	Sarissa Capital Compelled To Clarify Egregious Misstatements Made By Innoviva (PR Newswire)
10.04.17	ISS Supports All Three Sarissa Capital Nominees For Innoviva Board (PR Newswire)
06.04.17	Glass Lewis Supports Sarissa Capital's Nominees For Innoviva Board (PR Newswire)
04.04.17	Sarissa Capital Believes That Innoviva's Recent Statements Reinforce That Innoviva Is Being Run for the Benefit of Management and Not Shareholders (PR Newswire)
29.03.17	Sarissa Capital Responds To Innoviva's Many Misstatements (PR Newswire)
27.03.17	Sarissa Capital Files Presentation In Proxy Contest With Innoviva Highlighting Innoviva's Lack Of Shareholder Focus And Poor Corporate Governance (PR Newswire)
13.03.17	Sarissa Capital Responds To Innoviva's Preemptive Launch Of Proxy Contest (PR Newswire)
12.01.17	How These Application Software Stocks are Faring? -- Innoviva, Proofpoint, Manhattan Associates, and NQ Mobile (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Part Grp Hldg	1’263.50	2.89 %	K V
Sonova Hldg	312.10	2.66 %	K V
Novartis	93.68	2.32 %	K V
Geberit	526.80	1.97 %	K V
Roche Hldg G	254.30	1.27 %	K V
Kuehne+Nagel Int	209.50	0.72 %	K V
UBS Group	28.30	0.57 %	K V
Givaudan	3’933.00	0.36 %	K V
Nestle	76.00	0.05 %	K V
Lonza Grp	521.40	-0.04 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Innoviva

Aktien Top/Flop

Meistgelesene Nachrichten